Retour
Prix Infant Bacterial Therapeutics AB (publ) (IFTBF)
Graphique du cours de l'action IFTBF
IFTBF Gagner
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
À la fermeture : Jan 16, 16:00:00 GMT-5
$5.47
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$4.78
Prix d'ouverture
$5.47
Plage de la journée
$5.47 - $5.47
Plage de 52 semaines
$4.78 - $8.2
Volume
--
Volume moyen
1.0K
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que INFANT BACTERIAL THERAPEUTICS A ?
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved